04/07/2024 Healthcare
Gispin D 2.5/5 Tablets combine Linagliptin 2.5 mg and Dapagliflozin 5 mg. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that improves blood sugar control in type 2 diabetes by increasing insulin release and decreasing glucagon levels. Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes glucose excretion via urine. This dual-action combination helps manage blood glucose levels effectively, providing comprehensive treatment for type 2 diabetes mellitus.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations
Gispin D 2.5/5 Tablets combine Linagliptin 2.5 mg and Dapagliflozin 5 mg. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that improves bloo...
Rivaxa 2.5mg Tablet is an anticoagulant, commonly known as a blood thinner. It is used to prevent and treat blood clots and helps lower the risk of st...
Evertor 5mg Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body’s immune response, so the body can acce...
Jakavi 5mg Tablet is used in the treatment of chronic idiopathic myelofibrosis and Polycythemia vera. Jakavi 5mg Tablet - Ruxolitinib (20mg) - Novarti...
More Details